Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Retained Earnings: 2010-2025

Historic Retained Earnings for Myriad Genetics (MYGN) over the last 15 years, with Sep 2025 value amounting to -$1.1 billion.

  • Myriad Genetics' Retained Earnings fell 56.07% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 56.07%. This contributed to the annual value of -$756.8 million for FY2024, which is 20.22% down from last year.
  • Latest data reveals that Myriad Genetics reported Retained Earnings of -$1.1 billion as of Q3 2025, which was down 2.52% from -$1.1 billion recorded in Q2 2025.
  • Myriad Genetics' 5-year Retained Earnings high stood at -$246.6 million for Q3 2021, and its period low was -$1.1 billion during Q3 2025.
  • Over the past 3 years, Myriad Genetics' median Retained Earnings value was -$692.2 million (recorded in 2024), while the average stood at -$724.0 million.
  • Data for Myriad Genetics' Retained Earnings shows a maximum YoY plummeted of 124.89% (in 2021) over the last 5 years.
  • Over the past 5 years, Myriad Genetics' Retained Earnings (Quarterly) stood at -$254.2 million in 2021, then tumbled by 44.06% to -$366.2 million in 2022, then crashed by 71.90% to -$629.5 million in 2023, then declined by 20.22% to -$756.8 million in 2024, then plummeted by 56.07% to -$1.1 billion in 2025.
  • Its last three reported values are -$1.1 billion in Q3 2025, -$1.1 billion for Q2 2025, and -$756.9 million during Q1 2025.